OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
3
Results
Show all
Save search
Copy query
Show results for
Unknown
(2)
Proteomics
(1)
Organisms
Fusarium sinicum
(1)
Repository
PAXDB
(1)
Publication Date
2014
(1)
UNIPROT ID/AC
1433B_HUMAN
(1)
1433E_HUMAN
(1)
1433F_HUMAN
(1)
1433G_HUMAN
(1)
1433S_HUMAN
(1)
1433T_HUMAN
(1)
1433Z_HUMAN
(1)
2A5A_HUMAN
(1)
2A5D_HUMAN
(1)
2A5E_HUMAN
(1)
2A5G_HUMAN
(1)
2AAA_HUMAN
(1)
2AAB_HUMAN
(1)
2ABA_HUMAN
(1)
2ABD_HUMAN
(1)
3BHS1_HUMAN
(1)
3HIDH_HUMAN
(1)
41_HUMAN
(1)
4EBP2_HUMAN
(1)
4F2_HUMAN
(1)
5HT6R_HUMAN
(1)
5NT3A_HUMAN
(1)
5NTC_HUMAN
(1)
5NTD_HUMAN
(1)
6PGD_HUMAN
(1)
6PGL_HUMAN
(1)
8ODP_HUMAN
(1)
9606.ENSP00000233596
(1)
9606.ENSP00000268624
(1)
9606.ENSP00000291295
(1)
Release Date
2017
(1)
2011
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial.
Not available
S-EPMC3565012
|
biostudies-literature
Cite
A phase 2 trial of personalized cytotoxic therapy based on tumor immunohistochemistry in previously treated metastatic pancreatic cancer patients.
Not available
S-EPMC5750179
|
biostudies-literature
Cite
H.sapiens - Cell line, Pancreatic metastatic, SC (Kim,mcp,2014)
abundance based on Spectral counting, Pancreatic_metastatic, Interaction consistency score: 21.5, Coverage: 32
ORGANISM(S):
9606
2014-00-00
|
4148541313
|
PAXDB
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
